Digirad Corp (DRAD) Files Form 4 Insider Buying : Jeffrey E. Eberwein Buys 6,700 Shares

Digirad Corp (DRAD): Jeffrey E. Eberwein , director of Digirad Corp purchased 6,700 shares on May 27, 2016. The Insider buying transaction was reported by the company on Jun 1, 2016 to the Securities and Exchange Commission. The shares were purchased at $5.00 per share for a total value of $33,508.71 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 1, 2016, Matthew G. Molchan (President and CEO) sold 5,833 shares at $5.01 per share price.On Apr 7, 2016, Jeffrey E. Eberwein (director) purchased 11,700 shares at $4.91 per share price.Also, On Mar 15, 2016, Martin B Shirley (President, DIS) sold 46,700 shares at $4.91 per share price.

Shares of Digirad Corporation (DRAD) ended Wednesday, Jun 1, 2016 session in red amid volatile trading. The shares closed down -0.02 points or -0.40% at $5 with 1,85,871 shares getting traded. Post opening the session at $5.06, the shares hit an intraday low of $5 and an intraday high of $5.2 and the price vacillated in this range throughout the day. The company has a market cap of $98 M and the number of outstanding shares has been calculated to be 1,95,08,201 shares. The 52-week high of Digirad Corporation is $6.92 and the 52-week low is $3.5.

Digirad Corporation Money Flow Index Chart

Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services and also provides cardiac event monitoring services to physician practices hospitals and imaging centers through its Diagnostic Services business segment. The Company sells medical diagnostic imaging systems including solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications as well as provides service on the products it sells through its Diagnostic Imaging business segment. The Company’s imaging systems are sold in both portable (movable) and fixed (stationary) configurations which include Cardius XPO Cardius X-ACT and ergo gamma cameras.

Leave a Reply

Digirad Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Digirad Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.